Background: Dyslipidaemia is one of the cardiovascular risk factors responsible for cardiovascular disease and rapid progression of chronic kidney disease (CKD) to end stage renal disease. Early detection and management of dyslipidaemia will reduce cardiovascular burden and retard progression of CKD.Aims: To determine the prevalence and pattern of dyslipidaemia in pre-dialysis CKD patients in a tertiary hospital in southern Nigeria.Methods: This was a case-control study that involved 105 consecutive pre-dialysis CKD patients recruited over two years and 105 age and sex matched control subjects. Data obtained from participants included demographics, body mass index, and aetiology of CKD. Blood sampling was done for the determination of creat...
Background & Method: The present study is comparative observational study; entitled - To compare...
Background: Dyslipidemia and impaired glucose tolerance are common complications of chronic kidney d...
Background: There is dyslipidaemia in metabolic syndrome (MetS). Lipid profiles in MetS associated w...
Introduction: Longitudinal studies have established that Cardiovascular Disease (CVD) occur more fre...
Background: Cardiovascular risk factors are responsible for cardiovascular disease and rapid progres...
Objective: Chronic Kidney Disease (CKD) is a silent epidemic of the 21st century. Cardiovascular dis...
Background: The incidence and prevalence of chronic kidney disease (CKD) is increasing worldwide and...
Introduction: Longitudinal studies have established that Cardiovascular Disease (CVD) occur more fre...
Objective: To assess the fasting lipid profile in patients of chronic kidney disease presenting at t...
Introduction: Chronic kidney Disease is defined as abnormalities of kidney structure or function, pr...
Background: Recent epidemiological studies reported that chronic kidney disease (CKD) patients have ...
Background: Chronic Kidney Disease (CKD) hasan increased risk of cardiovascular diseases (CVD) preva...
Background: The burden of diabetes mellitus (DM), as well as that of chronic kidney disease (CKD) is...
Background: Prevalence of diabetes mellitus (DM) is on the increase in Nigeria with diabetic nephrop...
BACKGROUND Chronic kidney disease is a worldwide public health problem. The adverse outcomes of chr...
Background & Method: The present study is comparative observational study; entitled - To compare...
Background: Dyslipidemia and impaired glucose tolerance are common complications of chronic kidney d...
Background: There is dyslipidaemia in metabolic syndrome (MetS). Lipid profiles in MetS associated w...
Introduction: Longitudinal studies have established that Cardiovascular Disease (CVD) occur more fre...
Background: Cardiovascular risk factors are responsible for cardiovascular disease and rapid progres...
Objective: Chronic Kidney Disease (CKD) is a silent epidemic of the 21st century. Cardiovascular dis...
Background: The incidence and prevalence of chronic kidney disease (CKD) is increasing worldwide and...
Introduction: Longitudinal studies have established that Cardiovascular Disease (CVD) occur more fre...
Objective: To assess the fasting lipid profile in patients of chronic kidney disease presenting at t...
Introduction: Chronic kidney Disease is defined as abnormalities of kidney structure or function, pr...
Background: Recent epidemiological studies reported that chronic kidney disease (CKD) patients have ...
Background: Chronic Kidney Disease (CKD) hasan increased risk of cardiovascular diseases (CVD) preva...
Background: The burden of diabetes mellitus (DM), as well as that of chronic kidney disease (CKD) is...
Background: Prevalence of diabetes mellitus (DM) is on the increase in Nigeria with diabetic nephrop...
BACKGROUND Chronic kidney disease is a worldwide public health problem. The adverse outcomes of chr...
Background & Method: The present study is comparative observational study; entitled - To compare...
Background: Dyslipidemia and impaired glucose tolerance are common complications of chronic kidney d...
Background: There is dyslipidaemia in metabolic syndrome (MetS). Lipid profiles in MetS associated w...